These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36978242)

  • 1. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature.
    Leidl D; Takhar P; Li H
    Int J Ment Health Nurs; 2023 Oct; 32(5):1225-1242. PubMed ID: 36978242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
    Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
    Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
    Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
    Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-use of nicotine and prescription psychostimulants: A review of their behavioral and neuropharmacological interactions.
    McNealy KR; Weyrich L; Bevins RA
    Drug Alcohol Depend; 2023 Jul; 248():109906. PubMed ID: 37216808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substitution therapy tested against amphetamine dependence].
    Bloniecki Kallio V; Guterstam J; Franck J
    Lakartidningen; 2016 Jan; 113():. PubMed ID: 26756343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups.
    Soares E; Pereira FC
    Expert Opin Pharmacother; 2019 Dec; 20(18):2273-2293. PubMed ID: 31671001
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of psychostimulant drugs for cocaine dependence.
    Castells X; Casas M; Pérez-Mañá C; Roncero C; Vidal X; Capellà D
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007380. PubMed ID: 20166094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
    Downey LA; Loftis JM
    Eur J Pharmacol; 2014 Mar; 727():125-9. PubMed ID: 24485894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
    Vohra V; King A; Daviskiba S; Reed B; Rockhill S; Kern P; Dean D
    Clin Toxicol (Phila); 2021 Aug; 59(8):740-745. PubMed ID: 33295798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
    Rafizadeh R; Frankow L; Mahmood H; Poonia S; Mathew N; Danilewitz M; Bousman CA; Honer WG; Schütz CG
    J Psychopharmacol; 2023 Oct; 37(10):1040-1048. PubMed ID: 37539972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.
    Jones CM; Houry D; Han B; Baldwin G; Vivolo-Kantor A; Compton WM
    Ann N Y Acad Sci; 2022 Feb; 1508(1):3-22. PubMed ID: 34561865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Need for Examining the Role of Psychostimulants in Treatment of Methamphetamine Use/Dependence.
    Balon R
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):483-484. PubMed ID: 37930197
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.